Supreme Court rejects AstraZeneca plea against manufacturing of low-cost versions of its diabetes drug

Dapagliflozin is marketed in India by Sun Pharma and Abbott Healthcare through licensing agreements with the British firm.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...